Influence of clinical therapy and nutritional counseling on the recurrence of urolithiasis

Damasio, Patrícia Capuzzo Garcia; Amaro, Carmen Regina Petean Ruiz; Padovani, Carlos Roberto; Leitão, Victor A.; Yamamoto, Hamilto Akihissa; Amaro, João Luiz

doi:10.1590/s0102-86502014000600009

Cited by 9 publications

(6 citation statements)

References 19 publications

(24 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Urolithiasis is a condition that has been recognized for centuries and is the third most common cause of urinary tract disease [ 1 ]. Nearly 5% of females and 12% of males are likely to develop urolithiasis during their lifetime [ 2 ].…”

Section: Introductionmentioning

confidence: 99%

The G Allele of CaSR R990G Polymorphism Increases Susceptibility to Urolithiasis and Hypercalciuria: Evidences from a Comprehensive Meta-Analysis

Liu

Wang

et al. 2015

BioMed Research International

View full text Add to dashboard Cite

Background. The calcium-sensing receptor gene (CaSR) is a candidate to explain urolithiasis. A number of case-control studies were conducted to investigate associations between CaSR polymorphisms with risks of hypercalciuria and urolithiasis in humans. But the results were still inconsistent. Methods. A meta-analysis was performed to address this issue. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to estimate the strength of associations between CaSR polymorphisms and the risk of urolithiasis. The pooled standardized mean difference (SMD) with 95% CI was used for the meta-analysis of CaSR polymorphisms and urine calcium concentration. Results. For urolithiasis association, the SS genotype of A986S polymorphism was a risk factor for urolithiasis in Asians and PHPT patients, but a protective factor in Caucasians. The GG genotype of R990 polymorphism was associated with an increased risk of urolithiasis, especially in Caucasians and healthy population. Regarding urine calcium concentration association, individuals with the G allele had a higher level of urine calcium than the noncarriers. Conclusions. This meta-analysis revealed that the G allele of CaSR R990G polymorphism increases susceptibility to urolithiasis and hypercalciuria. The A986S and Q1011E polymorphisms were associated with urolithiasis and hypercalciuria in specific populations.

show abstract

Section: Introductionmentioning

confidence: 99%

The G Allele of CaSR R990G Polymorphism Increases Susceptibility to Urolithiasis and Hypercalciuria: Evidences from a Comprehensive Meta-Analysis

Liu

Wang

et al. 2015

BioMed Research International

View full text Add to dashboard Cite

show abstract

“…Stone formers should be recommended to increase their liquid intake to reduce the saturation of some compounds in urine and prevent the formation of calculi [10]. Additionally, patients should receive dietary recommendations such as reducing the intake of proteins and sodium and maintaining an adequate intake of calcium [11,16,[19][20][21][22].…”

Section: Discussionmentioning

confidence: 99%

A study of crystalluria: effectiveness of including hygienic-dietary recommendations in laboratory reports

Bailo

González

Álvarez

et al. 2021

Advances in Laboratory Medicine / Avances en Medicina De Laboratorio

View full text Add to dashboard Cite

Objectives To assess the effectiveness of incorporating hygienic-dietary recommendations in laboratory reports in reducing the incidence of renal colic (RC). A study was performed to compare the incidence of RC in two groups of patients who had suffered at least a crystalluria event associated with the risk of urolithiasis. Recommendations were only incorporated in the laboratory reports of one group. Methods A retrospective observational study. The study sample was composed of patients who had at least an episode of crystalluria associated with a higher risk of urolithiasis. The laboratory reports of patients in Group A (n=1,115), treated in 2017, did not include any hygienic-dietary recommendations, whereas patients in Group B (n=1,692), treated in 2018, received hygienic-dietary recommendations through their laboratory reports. χ2 and Mann-Whitney U test were used to assess differences based on sex, age, and type of urinary crystals. Results The incidence of RC was 2.02 times higher in group A (2.24%) than in group B (1.12%). No significant differences were observed in the incidence of RC based on the type of urinary crystal. The incidence of RC was substantially higher in patients who suffered at least an event of crystalluria associated with a higher risk for urolithiasis as compared to the general population during the same period (0.46%, consistently with the incidence rates reported in the literature). Conclusions The incorporation of messages alerting on the risk of urolithiasis and the inclusion of hygienic-dietary recommendations in laboratory reports may be useful for reducing the incidence of RC.

show abstract

“…Assessment with a registered dietician is strongly suggested where there is a history of compromised nutritional status, complex medical situations, or patients who need assistance implementing dietary recommendations. 39,40 Evidence suggests that patients who received specific dietary recommendations based on a comprehensive evaluation had fewer stone recurrences over 3 years than those who only received general dietary advice. 41 Adequate fluid intake to produce a urine output of 2.5L daily has been shown to reduce the risk of stone formation by 60-80% in several meta-analyses.…”

Section: General Dietary Measuresmentioning

confidence: 99%

Update – 2022 Canadian Urological Association guideline: Evaluation and medical management of the kidney stone patient

Bhojani

Bjazevic

Wallace

et al. 2022

CUAJ

View full text Add to dashboard Cite

with a high risk of recurrent stone disease undergo metabolic evaluation by any physician. 9 81% of patients interviewed would prefer to take prophylactic medication than undergo another stone episode, and 92% of respondents preferred medication to undergoing surgery. 10 Although patients indicate they would be interested in using medication to prevent future stones, compliance studies suggest otherwise. Close to 50% of patients prescribed pharmacological prevention were non-compliant, especially those on potassium citrate. 11 This data stresses the importance of a comprehensive metabolic assessment with implementaiton of individualized prevention strategies. With directed therapy and proper patient education, patient compliance and therapeutic success may be optimized.The economic burden of recurrent stone disease is also significant. Estimates of direct costs for patient care and the indirect costs related to lost work time exceed $5 billion USD. 12,13 Given the rising rates of obesity and diabetes and their association with stone formation, the cost of managing stone disease is expected to increase to 1.24 billion dollars yearly in the US by 2030. 14 This guideline is an update of the 2016 document and aims to identify patients at heightened risk of stone recurrence, to outline the required investigations to assess these patients, and to provide contemporary advice on dietary and medical interventions of proven benefit in the Canadian context. This current guideline addresses the evaluation and medical prophylaxis of upper urinary tract stones and not bladder stones. Literature reviewThe updated content included in this document is based on a review of the English language literature. A PubMed search was conducted encompassing the period from January 1, 2015 to July 1, 2021 to include the following terms: "nephrolithiasis", "urolithiasis", "kidney stone", "renal stone", or "urinary stone". In total, 11,640 article titles were reviewed and 293 were identified as potentially relevant for inclusion in the literature assessment for this guideline update. Management recommendations were modified if needed based on the most current literature since the last guideline was published in 2016. Studies were evaluated and recommendations made based on Oxford levels of evidence and grades of recommendation as per the CUA Guidelines Committee's directive. 15

show abstract

Influence of clinical therapy and nutritional counseling on the recurrence of urolithiasis

Cited by 9 publications

References 19 publications

The G Allele of CaSR R990G Polymorphism Increases Susceptibility to Urolithiasis and Hypercalciuria: Evidences from a Comprehensive Meta-Analysis

The G Allele of CaSR R990G Polymorphism Increases Susceptibility to Urolithiasis and Hypercalciuria: Evidences from a Comprehensive Meta-Analysis

A study of crystalluria: effectiveness of including hygienic-dietary recommendations in laboratory reports

Update – 2022 Canadian Urological Association guideline: Evaluation and medical management of the kidney stone patient

Contact Info

Product

Resources

About